Modelling Study Projects Rapid Growth in Radioligand Therapy Patient Populations Across EU and UK Healthcare Systems
By
Uwe Holzwartha Send email to [email protected]
Summary
This modelling study estimates the future patient populations eligible for radioligand therapies (RLTs) across EU-27 member states and the UK over the next decade. Using incidence data, the study projects a rapidly growing eligible patient pool that may overwhelm existing treatment capacity in European healthcare systems, even in countries with well-developed nuclear medicine infrastructure. The research highlights the need for coordinated efforts across all EU countries to ensure adequate patient access to RLTs and minimize health inequalities in cancer care.
Source
bskyModelling Study Projects Rapid Growth in Radioligand Therapy Patient Populations Across EU and UK Healthcare Systemsthelancet.comKey quotes
· 4 pulledThe eligible patient population for radioligand therapies (RLTs) has the potential to grow rapidly in the coming years.
European healthcare systems may be ill-prepared to provide the additional treatment capacity required on top of current workload.
The expected uptake of RLTs in EU healthcare systems over the coming decade may overwhelm available treatment capacity, even in countries with well-developed nuclear medicine infrastructure.
Efforts across all EU countries will be required to ensure adequate patient access to RLTs and to minimise health inequalities in cancer care.
You might also wanna read
Childhood cancer control in Asia: challenges and opportunities in paediatric oncology
This Series published in The Lancet Child & Adolescent Health and eClinicalMedicine examines the challenges and opportunities for childhood
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica
bmj.com·6d ago
European patients turn to AI chatbots for medical guidance amid healthcare gaps
Patients in Europe, particularly those with rare or complex conditions, are increasingly turning to AI chatbots like ChatGPT for medical adv
mdsc.pe·5d ago
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove
blog.google·8mo agoGPT-5.4 helped drive a medicinal chemistry project from literature review to a validated experimental result. Paired with Maria AI and specialized lab, the model proposed an unexpected way to improve
Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure
This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont
vectorculture.substack.com·5mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.